Study results inform discussions regarding US policy on lung transplantation …EurekAlert (press release)A new analysis has found no evidence that children aged 6 to 11 years seeking a deceased donor lung transplant are disadvantaged in the current US…
Entertainment calendar (Dec. 12-18, 2013) – High Point Enterprise
|
Entertainment calendar (Dec. 12-18, 2013)
High Point Enterprise Salem Saxophone Quartet performs Christmas jazz at 6:55 p.m. Admission is free; donations will be accepted for Sunnyside Ministry. HANDEL’S “MESSIAH” will be performed at 7:30 p.m. Tuesday and Wednesday at Centenary United Methodist Church, 646 … |
Brain-dead Man Gives New Lease of Life to Four People – The New Indian Express
The New Indian Express |
Brain-dead Man Gives New Lease of Life to Four People
The New Indian Express After his health condition deteriorated, he was shifted to the Christian Medical College (CMC) Hospital where he was declared brain dead. The doctors of CMC Hospital counselled Kumar’s family members for organ donation. After obtaining the consent of … |
European rabbis award prize to mobile blood donation app – Jerusalem Post
|
European rabbis award prize to mobile blood donation app
Jerusalem Post European rabbis award prize to mobile blood donation app. By HENRY ROME. 12/12/2013 04:12. Tweet. Council of European Rabbis gives 26,000 euro prize “Donor” app, created by Itsbeta, “encouraging Internet use for tikkun olam”. Blood drive [Illustrative]. |
Hackensack University Medical Center kidney transplant program fully reactivated – NorthJersey.com
|
Hackensack University Medical Center kidney transplant program fully reactivated
NorthJersey.com Since reopening May 17, eight transplants have been performed in the hospital, with successful outcomes, said Dr. James W. Lim, who took over as program director and chief of transplant surgery on April 18. “It was long and painstaking and took a lot … |
Minor undergoes rare liver transplant – Times of India
|
Minor undergoes rare liver transplant
Times of India “The mother’s left portion of the liver was implanted into the child and the right hepatic vein of the child was used to reconstruct the middle vein,” said Dr Thomas Cherian, liver transplant surgeon of the hospital, who performed the surgery. Both the … |
Blood donation collectors thrown out of Israeli parliament – Reuters
AFP |
Blood donation collectors thrown out of Israeli parliament
Reuters JERUSALEM (Reuters) – The speaker of Israel’s parliament ordered a blood-collection crew to leave the legislature’s premises on Wednesday after it turned down an offer of a blood donation from an Ethiopian-born lawmaker. Knesset member Pnina … MDA Accuses Ethiopian MK of Provocation over BloodArutz Sheva Magen David Adom Won’t Let Ethiopian Jewish Member Of Knesset Donate BloodFailedMessiah.com |
Targeted antibody, immune checkpoint blocker rein in follicular lymphoma – Medical Xpress
|
Targeted antibody, immune checkpoint blocker rein in follicular lymphoma
Medical Xpress “The combination of the established antibody drug rituximab with the experimental drug pidilizumab so far also has a remarkably mild side effect profile,” Neelapu said. Of 29 study participants at a median follow-up of 15.4 months, 19 (66 percent) had … |
Researchers Identify a New Way to Predict the Prognosis for Heart Failure Patients – Newswise (press release)
Irish Medical Times |
Researchers Identify a New Way to Predict the Prognosis for Heart Failure Patients
Newswise (press release) Newswise — Johns Hopkins researchers have identified a new way to predict which heart failure patients are likely to see their condition get worse and which ones have a better prognosis. Their study is one of the first to show that energy metabolism … New findings advance the opportunities for a ‘pacemaker in a bottle’Irish Medical Times |
Idelalisib With Rituximab Boosts Survival in Relapsed CLL – Medscape
|
Idelalisib With Rituximab Boosts Survival in Relapsed CLL
Medscape In a phase 3 trial, known as Study 116, the investigational agent idelalisib (under development by Gilead), when added to rituximab (Rituxan), improved outcomes in patients with relapsed CLL. “Idelalisib is a targeted, highly selective, orally … Idelalisib plus rituximab extended survival in previously treated CLLHealio Idelalisib/Rituximab Combo Improves Survival in Late-Stage CLLCancer Network Gilead’s Pipeline EncouragesYahoo News |